Peptides
11 articles on Peptides, written by Shotlee and medically reviewed for clinical accuracy.
The Science Behind the Peptide Craze
Peptides are surging in popularity among influencers and biohackers for everything from injury recovery to youthful skin, but the science lags far behind the hype. With FDA bans on key ones like BPC-157 and potential changes ahead, here's what you need to know about their evidence, safety, and gray-market realities.
5 min read
RFK Jr.'s Peptide Policy Could Boost Hims & Hers GLP-1 Shift
Shares of Hims & Hers surged after HHS Secretary RFK Jr. revealed FDA plans to review peptides for compounding under the 503A bulk list. This comes as the telehealth leader evolves its high-margin compounded GLP-1 business toward branded options and new peptide therapies. CEO Andrew Dudum and CMO Dr. Patrick Carroll highlight the potential for regulated, physician-led peptide access.
6 min read
What the War on Peptides Tells Us About Beauty's Future
Peptides are sweeping social media as injectables for clear skin, muscle gains, and fat loss, but a regulatory crackdown signals a war on unapproved versions. With FDA seizures, RFK Jr.'s advocacy, and black market persistence, what does this mean for beauty's future? Uncover the murky truths behind the hype.
5 min read
Hims & Hers Surges After RFK Jr. Pushes Peptide Access on Joe Rogan
Hims & Hers shares surged Monday after HHS Secretary Robert F. Kennedy Jr. expressed urgency on the Joe Rogan Experience to make 14 peptides more accessible. He highlighted FDA's review of the science behind these GLP-1 active ingredients for diabetes and weight loss. This could signal easing regulatory headwinds for telehealth providers like Hims.
5 min read
Supplement Makers Push FDA to Allow Peptides, New Ingredients
Makers of dietary supplements are pressing the FDA to permit peptides, probiotics, and other trendy ingredients not traditionally found in food. A pivotal public meeting highlighted industry pleas, RFK Jr.'s support, and warnings from consumer advocates. Here's what to know about this regulatory push reshaping the $100B+ supplement market.
6 min read
Supplement Makers Push FDA to Allow Peptides and New Ingredients
Dietary supplement makers are pressing the FDA to broaden ingredient criteria, potentially greenlighting peptides and probiotics not traditionally found in food. A key public meeting highlighted industry pleas under RFK Jr.'s health leadership, sparking debates on safety and oversight. Here's what this means for the booming wellness market.
6 min read
Peptide Gold Rush: Deregulation Set to Supercharge Shadow Industry
Peptides, once a Silicon Valley biohacking secret, are exploding in popularity—search interest now tops Ozempic. With RFK Jr. poised to reverse FDA restrictions, compounding pharmacies and telehealth platforms are racing to supply them legally. This could propel the $52B peptide market to $87B by 2035.
5 min read
Why Gym Bros Are Talking About Peptides: Hype, Science & Cautions
Peptides are everywhere on TikTok, with gym bros claiming stacks like Ipamorelin and CJC1295 supercharge muscle growth and recovery. But do these injectable amino acid chains really deliver, or is it hype? Experts weigh in on the science, safety, and why caution is key amid a $81.5 billion industry boom.
6 min read
Semax Peptide: Research on Neuroprotection, Inflammation, and Vascular Effects
Semax, a synthetic heptapeptide, has demonstrated neuroregulatory, neuroprotective, and immunomodulating properties in various research models. This article examines its biochemical characteristics, possible effects on gene expression, interactions with neurotransmitter systems, vascular modulation, metal binding, and utility in ischemia-reperfusion injury studies.
5 min read
Peptide CDMO 2.0 Market Outlook to 2034: Emphasizing Integrated and Tech-Forward CDMOs
The global peptide CDMO 2.0 market is poised for substantial growth, driven by increasing demand for peptide therapeutics and advancements in manufacturing technologies. This growth is fueled by the need for flexible, scalable, and efficient peptide production to meet the demands of both established pharmaceutical companies and emerging biotechs.
6 min read
Oral Proteins & Peptides Market to Reach USD 47.2 Billion Globally by 2035, Exhibiting 15.3% CAGR - TMR Study
The global market for oral proteins and peptides is experiencing rapid expansion, with projections estimating a value of US$ 47.2 billion by 2035. This growth, driven by increasing demand for peptide-based therapeutics and advancements in delivery technologies, signifies a dynamic shift in the pharmaceutical and nutraceutical landscape.
6 min read